TrialClinical rheumatology2022

Inactivated SARS-CoV-2 vaccine in primary Sjögren's syndrome: humoral response, safety, and effects on disease activity.

Sandra Gofinet Pasoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.